Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Serotonin type 3 receptor (5-HT3R) antagonists for negative symptoms and cognitive impairment associated with schizophrenia: a systematic review and meta-analysis
    Published on 2026-06-17
    1 month ago
  • Modulation of early non-rapid eye movement slow wave activity by ketamine in treatment-resistant depression
    Published on 2026-06-16
    1 month ago
  • Early life stress induces sex-specific changes in cognitive and affective behavior associated with disrupted noradrenergic physiology
    Published on 2026-06-15
    1 month ago
  • Phospholipase A2 downregulates inhibitory transmission in the amygdala and impairs fear extinction
    Published on 2026-06-15
    1 month ago
  • IN MEMORIUM – Roger E. Meyer, MD
    Published on 2026-06-12
    2 months ago
  • Nucleus accumbens medial shell D1 and D2 medium spiny neurons signal the valence of conditioned stimuli in a sex-dependent manner
    Published on 2026-06-11
    2 months ago
  • Effort, timing and choice: a refined rodent effort choice task with excellent sensitivity to dopamine modulators
    Published on 2026-06-10
    2 months ago
« Previous 1 … 5 6 7 8 9 … 143 Next »
Journal of Psychopharmacology
  • Effects of benzodiazepines on saccadic eye movements: A systematic review and meta-analysis
    Published on 2026-05-04
    3 months ago
  • 5-HT1A receptor blockade potentiates the subjective effects of DMT
    Published on 2026-05-02
    3 months ago
  • Effects of psychedelic use on authoritarian attitudes revisited
    Published on 2026-05-02
    3 months ago
  • Preliminary evidence that serum interleukin-6 is a candidate biomarker of response to esketamine in treatment-resistant depression
    Published on 2026-04-25
    3 months ago
  • The effects of the PDE4 inhibitor roflumilast on cognitive performance after a cerebrovascular accident: a double-blind randomized placebo-controlled trial with an open label extension (ROSTMEMA)
    Published on 2026-04-25
    3 months ago
  • Substance use predictors of arrest and self-reported criminal behavior in the United States: The role of psychedelics and rarely used drugs
    Published on 2026-04-16
    3 months ago
  • Mismatch negativity in patients with bipolar affective disorder: a systematic review and meta-analysis
    Published on 2026-04-16
    3 months ago
« Previous 1 … 5 6 7 8 9 … 150 Next »
European Neuropsychopharmacology
  • Perinatal bipolar disorder as a critical risk window: rationale for hospitalization at home on this population
    Published on 2026-04-17
    3 months ago
  • Pathway-selective signaling of serotonergic psychedelics at 5-HT receptors: Implications for psychoactivity, safety, and therapeutic potential
    Published on 2026-04-11
    4 months ago
  • Shared and distinct effects of mood stabilizers on epigenetic machinery gene expression: an exploratory study in HeLa cells
    Published on 2026-04-09
    4 months ago
  • Response to “Gene-environment interactions and white matter integrity in mood disorders: Further directions”
    Published on 2026-04-09
    4 months ago
  • Dissecting the pleiotropic genetic architecture of suicide attempt, suicidal ideation, and thirteen correlated traits
    Published on 2026-04-07
    4 months ago
  • Structural brain findings associated with clinical profiles but not diagnosis in unmedicated adults with obsessive-compulsive disorder: the Global OCD study
    Published on 2026-04-03
    4 months ago
  • Sexual dysfunction in bipolar disorder: A systematic review
    Published on 2026-04-01
    4 months ago
« Previous 1 … 5 6 7 8 9 … 168 Next »

 

Psychopharmacology
  • Shorter to be effective: subanesthetic-dose ketamine infusion reduces the global and regional path length of brain functional connectivity in patients with treatment-resistant depression and suicidal ideation
    Published on 2026-05-22
    2 months ago
  • Golden window of intervention in PTSD: a synthesis of preclinical evidence
    Published on 2026-05-21
    2 months ago
  • Transcriptional profiling reveals brain region-specific changes in gene expression induced by chronic unpredictable mild stress between stress-susceptible and stress-resilient mice
    Published on 2026-05-20
    2 months ago
  • Correction to: Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment
    Published on 2026-05-19
    2 months ago
  • β-caryophyllene, a CB2-selective phytocannabinoid, differentially modulates attention and inhibitory control in low- and high-performing young and aged mice
    Published on 2026-05-18
    2 months ago
  • Corticosteroid-Induced neuropsychiatric manifestations: From pathophysiology to management
    Published on 2026-05-14
    2 months ago
  • Spironolactone and clinical outcomes in patients with alcohol use disorder and comorbid hypertension: a target trial emulation study
    Published on 2026-05-14
    2 months ago
« Previous 1 … 5 6 7 8 9 … 414 Next »
International Journal of Neuropsychopharmacology
  • 472. EFFECTS OF GLT-1 MODULATOR, MC-100093, ON NEUROINFLAMMATORY FACTOR IN MESOCORTICOLIMBIC BRAIN REGIONS OF FEMALE P RATS EXPOSED CHRONICALLY TO ETHANOL
    Published on 2025-08-18
    11 months ago
  • 380. THE EFFECT OF BRIGHT LIGHT THERAPY ON SYMPTOMS AND COGNITIVE FUNCTION IN PATIENTS WITH SCHIZOPHRENIA
    Published on 2025-08-18
    11 months ago
  • 515. TO EXPLORE THE EFFECT OF PSYCHOPHYSIOLOGICAL MARKERS FOR STRESS REGULATION IN PATIENTS WITH SCHIZOPHRENIA: AN IMPLICATION OF CARDIOVASCULAR RISK
    Published on 2025-08-18
    11 months ago
  • 460. DIETARY CUPRIZONE AND GESTATIONAL THC EXPOSURE BOTH INDUCE LOCALIZED DEPLETION OF BRAIN COPPER
    Published on 2025-08-18
    11 months ago
  • 203. PSYCHOTROPICS USE AND OCCURRENCE OF FALLS IN HOSPITALIZED PATIENTS: A MATCHED CASE-CONTROL STUDY
    Published on 2025-08-18
    11 months ago
  • 466. ASSESSING AND MANAGING CIGARETTE SMOKING AMONG PSYCHIATRIC INPATIENTS: CLINICAL AND SOCIODEMOGRAPHIC IMPLICATIONS
    Published on 2025-08-18
    11 months ago
  • 621. MENTAL HEALTH AUSTRALIA GENERAL CLINICAL TRIAL NETWORK (MAGNET) – CONNECTING KNOWLEDGE FOR BETTER MENTAL HEALTH OUTCOMES
    Published on 2025-08-18
    11 months ago
« Previous 1 … 5 6 7 8 9 … 237 Next »
Frontiers in Pharmacology
  • Bruceine E, a natural quassinoid from Brucea javanica, inhibits PARthanatos via targeting PARP1 in ischemic stroke
    Published on 2026-06-22
    1 month ago
  • Chronic inhibition of receptor protein tyrosine phosphatase β/ζ reduces amyloid plaque load and modulates pleiotrophin-expressing glial cells, glial-plaque interactions and genes related to amyloid beta clearance
    Published on 2026-06-19
    1 month ago
  • Artificial cerebrospinal fluid preserves neuronal viability and attenuates apoptosis and oxidative stress in HT22 cells
    Published on 2026-06-19
    1 month ago
  • Mechanism-informed neuroprotection in acute ischemic stroke treated with thrombectomy: a systematic review and meta-analysis of randomized controlled trials
    Published on 2026-06-17
    1 month ago
  • The METOD study: exploring metabolism, emotional blunting and treatment outcomes in depression – A naturalistic, two-phase observational protocol
    Published on 2026-06-17
    1 month ago
  • 2-Pentadecyl-2-oxazoline alleviates anxiety-like behaviour and modulates the microbiota-gut-brain axis in obese mice
    Published on 2026-06-17
    1 month ago
  • Comparative efficacy of botulinum toxin and surgical treatment for acute acquired concomitant esotropia: a systematic review and meta-analysis
    Published on 2026-06-17
    1 month ago
« Previous 1 … 5 6 7 8 9 … 276 Next »

 

Translational Psychiatry
  • Glucagon-like peptide-1 receptor activation and mental health: a drug-target mendelian randomization study
    Published on 2026-07-13
    2 weeks ago
  • Mapping lncRNAs onto multilevel mRNA co‑expression modules in autism
    Published on 2026-07-13
    2 weeks ago
  • Widespread white matter microstructural abnormalities in treatment‑naïve patients with first‑episode schizophrenia revealed by fixel-based analysis
    Published on 2026-07-13
    2 weeks ago
  • Increased activity of DRD1-MSNs in dorsolateral striatum underlies Cry1Δ11 mutation-induced repetitive behaviors
    Published on 2026-07-13
    2 weeks ago
  • Investigation of polygenic risk scores and subphenotypes in social anxiety disorder
    Published on 2026-07-11
    2 weeks ago
  • Phenotyping antidepressant treatment response with deep learning in electronic health records
    Published on 2026-07-11
    2 weeks ago
  • Functional connectivity changes in obsessive-compulsive disorder following exposure and response prevention
    Published on 2026-07-11
    2 weeks ago
« Previous 1 … 5 6 7 8 9 … 310 Next »
Molecular Psychiatry
  • A population-level approach to the treatment of psychiatric disorders
    Published on 2026-07-08
    3 weeks ago
  • Convergent increases in serotonin 1B receptor binding following ketamine and electroconvulsive therapy: a multi-centre bayesian re-analysis of PET data
    Published on 2026-07-08
    3 weeks ago
  • α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice
    Published on 2026-07-07
    3 weeks ago
  • Molecular genetic influences on sustained attention and executive processes and their links with psychopathology in the AFFECT study
    Published on 2026-07-07
    3 weeks ago
  • Cognitive and affective effects of L-Theanine: a systematic review and meta-analysis of 31 randomized trials
    Published on 2026-07-06
    3 weeks ago
  • Depression in neurodegenerative disease: neurobiological mechanisms and emerging treatments
    Published on 2026-07-06
    3 weeks ago
  • Nonsense-mediated decay influences position-dependent effects of SCN2A premature stop codons on neuronal excitability and behavior
    Published on 2026-07-06
    3 weeks ago
« Previous 1 … 5 6 7 8 9 … 299 Next »
Nature Reviews Neuroscience
  • Computational origins of cortical brain circuits for social cognition
    Published on 2026-02-15
    5 months ago
  • Rhythms alone cannot explain subjective time
    Published on 2026-01-25
    6 months ago
  • Reply to ‘Rhythms alone cannot explain subjective time’
    Published on 2026-01-25
    6 months ago
  • A roadmap for conducting more inclusive research on brain resilience in ageing and dementia
    Published on 2026-01-22
    6 months ago
  • Cracking the code of gut–brain sensing
    Published on 2026-01-22
    6 months ago
  • Sensory neuron signals drive bone repair
    Published on 2026-01-21
    6 months ago
  • Environmental decision neuroscience connects the brain to climate action
    Published on 2026-01-20
    6 months ago
« Previous 1 … 5 6 7 8 9 … 67 Next »

 

CNS Spectrum
  • Understanding the delivery technology used in ADHD stimulant medications can help to individualize treatment
    Published on 2025-02-12
    1 year ago
  • From assessment to intervention: evidence-based approaches in tardive dyskinesia
    Published on 2025-02-11
    1 year ago
  • Dispositional mindfulness, interoceptive awareness, and panic-agoraphobic spectrum, in a general population sample
    Published on 2025-02-09
    1 year ago
  • Current progress in targeted pharmacotherapy to treat symptoms of major depressive disorder: moving from broad-spectrum treatments to precision psychiatry
    Published on 2025-02-06
    1 year ago
  • Love is expensive: the impact of initiating versus terminating romantic relationships on the onset of obsessive-compulsive disorder
    Published on 2025-01-30
    1 year ago
  • MDMA-assisted therapy: challenges, clinical trials, and the future of MDMA in treating behavioral disorders
    Published on 2025-01-29
    1 year ago
  • Assisted outpatient treatment: are court-ordered antipsychotic medications effective?
    Published on 2025-01-27
    1 year ago
« Previous 1 … 5 6 7 8 9 … 96 Next »
Neuropharmacology
  • Corrigendum to “Preventive effects of a standardized flavonoid extract of safflower in rotenone-induced Parkinson’s disease rat model” [Neuropharmacology 217 (2022) 109209]
    Published on 2026-06-05
    2 months ago
  • NOP receptor activation counteracts stress-induced migraine-like behaviors in mice
    Published on 2026-06-04
    2 months ago
  • Corrigendum to “Erythropoietin targets parvalbumin-positive inhibitory neurons and microglia to promote plasticity in the thalamic reticular nucleus” [Neuropharmacology 297 (2026) 111025]
    Published on 2026-06-04
    2 months ago
  • Endomorphin analogs CEMR-1 and CEMR-2 administered intravenously display potent antinociception with limited tolerance in acute, neuropathic and inflammatory pain
    Published on 2026-06-04
    2 months ago
  • Editorial Board
    Published on 2026-06-04
    2 months ago
  • Targeting P2X receptor signaling for chronic visceral pain and beyond
    Published on 2026-06-04
    2 months ago
  • Exploring the Therapeutic Potential of Hesperidin Nanoparticles, Carbidopa-levodopa, or Their Combined Administration in a Rat Model of Reserpine-Induced Parkinsonism
    Published on 2026-06-03
    2 months ago
« Previous 1 … 5 6 7 8 9 … 190 Next »
Nature
  • How do quantum computers work?
    Published on 2026-07-22
    6 days ago
  • Subnuclear genome compartmentalization controls bivalent chromatin activity
    Published on 2026-07-22
    6 days ago
  • Polio should have been eradicated by now. What’s plan B?
    Published on 2026-07-22
    6 days ago
  • Non-epitaxial perovskite polariton laser diode operating under direct current
    Published on 2026-07-22
    6 days ago
  • A global molecular code for birth order and neuronal identity in Drosophila
    Published on 2026-07-22
    6 days ago
  • Here’s what’s next for the Artemis II astronauts
    Published on 2026-07-22
    6 days ago
  • Planetary-mass exosatellite detected around the substellar companion of a star
    Published on 2026-07-22
    6 days ago
« Previous 1 … 5 6 7 8 9 … 2,560 Next »

   Pharma Pub